# Metropolis Healthcare Ltd (METROPOLIS)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹528.8
Day Change: +2.03%
52W High: ₹600
52W Low: ₹400.4
Market Cap: ₹10,520 Cr

## Valuation
P/E: 55.15
P/B: 7.34
EPS: ₹9.2
Book Value: ₹69.15
Dividend Yield: 0%

## Returns
1Y Return: 2.92%

## Profitability
ROE: 13.37%
ROCE: 17.07%
Debt/Equity: 0.15
Revenue Growth: 25.4%
Profit Growth: 73%
EBITDA Margin: 25.51%
Operating Margin: 17.92%

## About
Metropolis Healthcare Ltd is a Diagnostics & Research company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Metropolis Healthcare Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:58:25.837Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:25.837Z
Quant Updated: 2026-05-18T22:58:25.837Z
Sentiment Updated: 2026-05-18T22:58:25.837Z
Financials Status: current
Financials Updated: 2026-05-18T10:31:50.393Z
Financials Last Attempt: 2026-05-18T10:31:50.393Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹456 Cr
Operating Profit: ₹117 Cr (OPM 26%)
Net Profit: ₹68 Cr
Tax: ₹101 Cr

## Annual P&L History
Mar 2016: Rev ₹456Cr | PAT ₹68Cr | OPM 26%
Mar 2017: Rev ₹475Cr | PAT ₹82Cr | OPM 24%
Mar 2018: Rev ₹545Cr | PAT ₹107Cr | OPM 26%

## Balance Sheet (Mar 2016)
Total Assets: ₹462 Cr
Total Liabilities: ₹462 Cr
Borrowings: ₹14 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ameera Sushil Shah, Executive Chairperson
- Sushil Kanubhai Shah, Founder, Non-Executive Director & Chairman Emeritus
- Surendran  Chemmenkotil, Chief Executive Officer
- Sameer Prakash Patel, Chief Financial Officer
- Kirti  Chadha, Chief Scientific & Innovation Officer

---
Source: rupiya.io/stocks/metropolis
Disclaimer: For research and education only. Not investment advice.